Management of Depression in Older Adults: A Review

Importance Depression in older adults is a common psychiatric disorder affecting their health-related quality of life. Major depression occurs in 2% of adults aged 55 years or older, and its prevalence rises with increasing age. In addition, 10% to 15% of older adults have clinically significant depressive symptoms, even in the absence of major depression. Observations Depression presents with the same symptoms in older adults as it does in younger populations. In contrast to younger patients, older adults with depression more commonly have several concurrent medical disorders and cognitive impairment. Depression occurring in older patients is often undetected or inadequately treated. Antidepressants are the best-studied treatment option, but psychotherapy, exercise therapy, and electroconvulsive therapy may also be effective. Psychotherapy is recommended for patients with mild to moderate severity depression. Many older patients need the same doses of antidepressant medication that are used for younger adult patients. Although antidepressants may effectively treat depression in older adults, they tend to pose greater risk for adverse events because of multiple medical comorbidities and drug-drug interactions in case of polypharmacy. High-quality evidence does not support the use of pharmacologic treatment of depression in patients with dementia. Polypharmacy in older patients can be minimized by using the Screening Tool of Older Persons Prescriptions and Screening Tool to Alert doctors to Right Treatment (STOPP/START) criteria, a valid and reliable screening tool that enables physicians to avoid potentially inappropriate medications, undertreatment, or errors of omissions in older people. Antidepressants can be gradually tapered over a period of several weeks, but discontinuation of antidepressants may be associated with relapse or recurrence of depression, so the patient should be closely observed. Conclusions and Relevance Major depression in older adults is common and can be effectively treated with antidepressants and electroconvulsive therapy. Psychological therapies and exercise may also be effective for mild-moderate depression, for patients who prefer nonpharmacological treatment, or for patients who are too frail for drug treatments.

[1]  I. Katz,et al.  Pharmacotherapy of Depression in Older Patients: A Summary of the Expert Consensus Guidelines , 2001, Journal of psychiatric practice.

[2]  B. Mulsant,et al.  Efficacy, safety, and tolerability of augmentation pharmacotherapy with aripiprazole for treatment-resistant depression in late life: a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[3]  T. Gill,et al.  Under-treatment of depression in older persons. , 2012, Journal of affective disorders.

[4]  J. Avorn,et al.  Suboptimal Antidepressant Use in the Elderly , 2005, Journal of clinical psychopharmacology.

[5]  Wayne Katon,et al.  Depression and Comorbid Illness in Elderly Primary Care Patients: Impact on Multiple Domains of Health Status and Well-being , 2004, The Annals of Family Medicine.

[6]  N. Meader,et al.  Which version of the geriatric depression scale is most useful in medical settings and nursing homes? Diagnostic validity meta-analysis. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[7]  Alan J. Thomas,et al.  Depression and dementia: cause, consequence or coincidence? , 2014, Maturitas.

[8]  B. Wiese,et al.  Age- and gender-specific prevalence of depression in latest-life--systematic review and meta-analysis. , 2012, Journal of affective disorders.

[9]  Yeh-Fong Chen,et al.  Review of maintenance trials for major depressive disorder: a 25-year perspective from the US Food and Drug Administration. , 2014, The Journal of clinical psychiatry.

[10]  M. McCabe,et al.  An examination of the "gold standard" diagnosis of major depression in aged-care settings. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[11]  S. Crowe,et al.  Persistence of cognitive effects after withdrawal from long-term benzodiazepine use: a meta-analysis. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[12]  G. Livingston,et al.  How well do antidepressants work in older people? A systematic review of Number Needed to Treat. , 2002, Journal of affective disorders.

[13]  David Rindskopf,et al.  Design makes a difference: a meta-analysis of antidepressant response rates in placebo-controlled versus comparator trials in late-life depression. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[14]  F. Bellavance,et al.  Prognosis of depression in elderly community and primary care populations: a systematic review and meta-analysis. , 1999, The American journal of psychiatry.

[15]  Y. Lerman,et al.  Intervention with the Screening Tool of Older Persons Potentially Inappropriate Prescriptions/Screening Tool to Alert Doctors to Right Treatment Criteria in Elderly Residents of a Chronic Geriatric Facility: A Randomized Clinical Trial , 2014, Journal of the American Geriatrics Society.

[16]  L. Rubenstein,et al.  Comprehensive geriatric assessment: a meta-analysis of controlled trials , 1993, The Lancet.

[17]  J. Mårtensson,et al.  Can selective serotonin inhibitor drugs in elderly patients in nursing homes be reduced? , 2007, Scandinavian journal of primary health care.

[18]  D. Seitz,et al.  Meta‐analysis of problem solving therapy for the treatment of major depressive disorder in older adults , 2016, International journal of geriatric psychiatry.

[19]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[20]  R. Wredling,et al.  Controlled withdrawal of selective serotonin reuptake inhibitor drugs in elderly patients in nursing homes with no indication of depression , 2003, European Journal of Clinical Pharmacology.

[21]  G. Selbæk,et al.  Screening for depression in elderly medical inpatients from rural area of Norway: prevalence and associated factors , 2010, International journal of geriatric psychiatry.

[22]  A. Beekman,et al.  Review of community prevalence of depression in later life , 1999, British Journal of Psychiatry.

[23]  G. Sergi,et al.  Polypharmacy in the Elderly , 2011, Drugs & aging.

[24]  N. Purandare,et al.  Prevalence of psychiatric disorders among older adults in long-term care homes: a systematic review , 2010, International Psychogeriatrics.

[25]  R. Schoevers,et al.  Risk factors for anxiety and depression in the elderly: a review. , 2008, Journal of affective disorders.

[26]  M. Maj,et al.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression , 2009, Metabolic Brain Disease.

[27]  Paul Gallagher,et al.  STOPP/START criteria for potentially inappropriate prescribing in older people: version 2 , 2014, Age and ageing.

[28]  J. K. Djernes,et al.  Prevalence and predictors of depression in populations of elderly: a review , 2006, Acta psychiatrica Scandinavica.

[29]  P. Verhaak,et al.  The role of frailty in the association between depression and somatic comorbidity: results from baseline data of an ongoing prospective cohort study. , 2015, International journal of nursing studies.

[30]  Sati Mazumdar,et al.  Maintenance treatment of major depression in old age. , 2006, The New England journal of medicine.

[31]  K. Wilson,et al.  Antidepressants versus placebo for the depressed elderly , 2001 .

[32]  P. Sienaert,et al.  Speed of remission in elderly patients with depression: electroconvulsive therapy v. medication. , 2015, The British journal of psychiatry : the journal of mental science.

[33]  P. Cuijpers,et al.  Managing depression in older age: psychological interventions. , 2014, Maturitas.

[34]  K. Thorlund,et al.  Comparative Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin‐Norepinephrine Reuptake Inhibitors in Older Adults: A Network Meta‐Analysis , 2015, Journal of the American Geriatrics Society.

[35]  W. Stigelman,et al.  Goodman and Gilman's the Pharmacological Basis of Therapeutics , 1986 .

[36]  A. Mitchell,et al.  A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. , 2009, Journal of psychiatric research.

[37]  J. Yesavage,et al.  Geriatric Depression Scale (GDS): Recent evidence and development of a shorter version. , 1986 .

[38]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.

[39]  K. Wilson,et al.  Antidepressant versus placebo for depressed elderly. , 2001, The Cochrane database of systematic reviews.

[40]  W. Taylor Clinical practice. Depression in the elderly. , 2014, The New England journal of medicine.

[41]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[42]  P. Doraiswamy,et al.  A Systematic Review of Antidepressant Placebo-Controlled Trials for Geriatric Depression: Limitations of Current Data and Directions for the Future , 2004, Neuropsychopharmacology.

[43]  Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence , 2010 .

[44]  Alan J. Thomas,et al.  Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial , 2011, The Lancet.

[45]  P. Rabins,et al.  A systematic review of treatments for refractory depression in older people. , 2011, The American journal of psychiatry.

[46]  R. Sysko,et al.  Placebo response in studies of major depression: variable, substantial, and growing. , 2002, JAMA.

[47]  Alison Evans,et al.  Antidepressants for depression in physically ill people. , 2010, The Cochrane database of systematic reviews.

[48]  Maurizio Fava,et al.  Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD , 2009, European Neuropsychopharmacology.

[49]  P A Parmelee,et al.  Geriatric Depression Scale , 2002 .

[50]  P. Wilkinson,et al.  Continuation and maintenance treatments for depression in older people. , 2016, The Cochrane database of systematic reviews.

[51]  D. Devanand,et al.  A Systematic Review and Meta‐Analysis of Placebo‐Controlled Antidepressant Studies in People with Depression and Dementia , 2011, Journal of the American Geriatrics Society.

[52]  J. Unützer,et al.  Older adults with severe, treatment-resistant depression. , 2012, JAMA.

[53]  R. Kok What is the role of medications in late life depression? , 2013, The Psychiatric clinics of North America.

[54]  M. Goldstein,et al.  Health Outcomes Associated with Polypharmacy in Community‐Dwelling Older Adults: A Systematic Review , 2014, Journal of the American Geriatrics Society.

[55]  W. Nolen,et al.  Continuing treatment of depression in the elderly: a systematic review and meta-analysis of double-blinded randomized controlled trials with antidepressants. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[56]  W. Nolen,et al.  Efficacy of treatment in older depressed patients: a systematic review and meta-analysis of double-blind randomized controlled trials with antidepressants. , 2012, Journal of affective disorders.

[57]  G. Sanacora,et al.  Towards a glutamate hypothesis of depression An emerging frontier of neuropsychopharmacology for mood disorders , 2012, Neuropharmacology.

[58]  S. Gilbody,et al.  The diagnostic accuracy of brief versions of the Geriatric Depression Scale: a systematic review and meta‐analysis , 2016, International journal of geriatric psychiatry.

[59]  Liang Feng,et al.  Frailty predicts new and persistent depressive symptoms among community-dwelling older adults: findings from Singapore longitudinal aging study. , 2014, Journal of the American Medical Directors Association.

[60]  K. Shulman,et al.  The efficacy, safety and tolerability of antidepressants in late life depression: a meta-analysis. , 1997, Journal of affective disorders.

[61]  K. Wilson,et al.  Antidepressants for depressed elderly. , 2006, The Cochrane database of systematic reviews.

[62]  Jiska Cohen-Mansfield,et al.  Psychosocial interventions for dementia patients in long-term care , 2010, International Psychogeriatrics.

[63]  L. Schneider,et al.  Moderators of outcome in late-life depression: a patient-level meta-analysis. , 2013, The American journal of psychiatry.

[64]  S. Lamb,et al.  Effect of exercise on depression severity in older people: systematic review and meta-analysis of randomised controlled trials , 2012, British Journal of Psychiatry.

[65]  K. Zivin,et al.  Adherence to Depression Treatment in Older Adults , 2008, Drugs & aging.

[66]  E. Binder,et al.  Epigenetics, depression and antidepressant treatment. , 2012, Current pharmaceutical design.

[67]  V. Naganathan,et al.  Medication Withdrawal Trials in People Aged 65 Years and Older , 2008, Drugs & aging.

[68]  I. Katz,et al.  The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients. , 2001, Postgraduate medicine.

[69]  R. Kessler,et al.  Age differences in major depression: results from the National Comorbidity Survey Replication (NCS-R) , 2009, Psychological Medicine.

[70]  A. Mitchell,et al.  Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. , 2005, The American journal of psychiatry.

[71]  E. Giltay,et al.  Phenomenology of depression in older compared with younger adults: meta-analysis. , 2012, The British journal of psychiatry : the journal of mental science.

[72]  R. L. Gould,et al.  Cognitive Behavioral Therapy for Depression in Older People: A Meta‐Analysis and Meta‐Regression of Randomized Controlled Trials , 2012, Journal of the American Geriatrics Society.

[73]  J. Hanlon,et al.  A review of the effectiveness of antidepressant medications for depressed nursing home residents. , 2012, Journal of the American Medical Directors Association.

[74]  Mauro Giovanni Carta,et al.  Physical Activity in Depressed Elderly. A Systematic Review , 2013, Clinical practice and epidemiology in mental health : CP & EMH.

[75]  J. Markowitz,et al.  Practice guideline for the treatment of patients with major depressive disorder (revision). American Psychiatric Association. , 2000, The American journal of psychiatry.

[76]  F. Bellavance,et al.  Effectiveness of treatments of depression in older ambulatory patients. , 1998, Archives of internal medicine.

[77]  S. Crowe,et al.  Cognitive Effects of Long-Term Benzodiazepine Use , 2004, CNS Drugs.

[78]  O. Cauli,et al.  The relationship between depression and frailty syndrome: a systematic review , 2015, Aging & mental health.

[79]  George I Papakostas,et al.  Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials. , 2011, The Journal of clinical psychiatry.

[80]  M. Pinquart,et al.  Treatments for later-life depressive conditions: a meta-analytic comparison of pharmacotherapy and psychotherapy. , 2006, The American journal of psychiatry.

[81]  D J Kupfer,et al.  Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than 59 years. , 1999, JAMA.

[82]  Matteo Cesari,et al.  Frailty consensus: a call to action. , 2013, Journal of the American Medical Directors Association.

[83]  E. Nestler,et al.  Epigenetic mechanisms of depression and antidepressant action. , 2013, Annual review of pharmacology and toxicology.

[84]  Paul Gallagher,et al.  STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. , 2008, Age and ageing.

[85]  A. Serretti,et al.  Antidepressants in elderly: metaregression of double-blind, randomized clinical trials. , 2013, Journal of affective disorders.

[86]  D. Adson,et al.  Update on drug-induced depression in the elderly. , 2005, The American journal of geriatric pharmacotherapy.

[87]  K. Wilson,et al.  Psychotherapeutic treatments for older depressed people. , 2008, The Cochrane database of systematic reviews.